Video Experimental Relacionado
Updated: Mar 24, 2026
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
3.3K
La base de la oncoinmunología
A Karolina Palucka1, Lisa M Coussens2
1The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Cell
|March 12, 2016
Resumen
Aprovechar el sistema inmunológico, particularmente las células T, puede superar la heterogeneidad del cáncer y la resistencia a la terapia. La investigación futura tiene como objetivo mejorar los tratamientos contra el cáncer apuntando a la inflamación y la actividad de las células T dentro del microambiente tumoral.
Área de la Ciencia:
- Inmunología
- En el campo de la oncología
- Investigación del cáncer
Sus antecedentes:
- La heterogeneidad del cáncer impulsa la supervivencia clonal y la resistencia a las terapias.
- Las respuestas inmunes, especialmente las células T específicas de antígenos, juegan un papel crucial en el control del cáncer.
- Las inmunoterapias actuales como la transferencia de células T adoptivas y el bloqueo de puntos de control demuestran el potencial de la modulación del sistema inmunológico.
Objetivo del estudio:
- Explorar cómo se puede utilizar mejor el sistema inmunológico del huésped para mejorar la eficacia de la terapia citotóxica contra el cáncer.
- Identificar las fronteras de la investigación esenciales para mejorar los resultados del tratamiento del cáncer.
- Desarrollar estrategias para superar la resistencia a las terapias actuales contra el cáncer.
Principales métodos:
- Investigando métodos para neutralizar la inflamación que promueve el tumor.
- Explorar estrategias para ampliar el repertorio de células T, incluida la vacunación.
- Mecanismos de aclaración de la organización de las células inmunes dentro de los microambientes tumorales para regular la actividad de las células T.
Principales resultados:
- Las respuestas inmunes activas, particularmente las células T, dan forma a la heterogeneidad del cáncer e influyen en la resistencia al tratamiento.
- La inmunoterapia destaca el potencial de las células T en el control del cáncer.
- Comprender las interacciones de las células inmunes es clave para modular el microambiente tumoral.
Conclusiones:
- Aprovechar el sistema inmunológico ofrece un enfoque poderoso para mejorar la terapia citotóxica y mejorar los resultados del paciente.
- Abordar la inflamación que promueve el tumor, expandir la diversidad de células T y comprender la regulación inmune son áreas de investigación críticas.
- Estos esfuerzos conducirán a nuevas terapias combinadas para combatir la resistencia al tratamiento y lograr el control del cáncer a largo plazo.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
613
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
613
01:27Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K